Laboratorios Farmaceuticos ROVI (ROVI) — Strategic Asset Allocation Index
Laboratorios Farmaceuticos ROVI (ROVI) has a Strategic Asset Allocation Index of 40.9% as of September 2023. Strategic assets (PP&E of €226.66 Million plus long-term investments of €-) total €226.66 Million, measured against net assets of €554.64 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Laboratorios Farmaceuticos ROVI to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Laboratorios Farmaceuticos ROVI Strategic Asset Allocation Index (2003–2022)
This chart shows how Laboratorios Farmaceuticos ROVI's Strategic Asset Allocation Index has evolved across 20 annual periods from 2003 to 2022. As of September 2023, the index stands at 40.9%, representing strategic assets of €226.66 Million against net assets of €554.64 Million EUR. See Laboratorios Farmaceuticos ROVI (ROVI) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Laboratorios Farmaceuticos ROVI (2003–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Laboratorios Farmaceuticos ROVI from 2003 to 2022, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ROVI market cap.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 41.3% | €215.54 Million | €215.54 Million | €- | €521.38 Million | ▲ +2.7 pp |
| 2021 | 38.6% | €181.78 Million | €181.78 Million | €- | €470.98 Million | ▼ -3.0 pp |
| 2020 | 41.6% | €155.40 Million | €155.40 Million | €- | €373.70 Million | ▲ +0.2 pp |
| 2019 | 41.4% | €133.52 Million | €131.61 Million | €1.91 Million | €322.39 Million | ▲ +7.3 pp |
| 2018 | 34.1% | €97.94 Million | €95.84 Million | €2.11 Million | €287.47 Million | ▼ -13.5 pp |
| 2017 | 47.6% | €91.18 Million | €89.06 Million | €2.12 Million | €191.69 Million | ▲ +1.0 pp |
| 2016 | 46.6% | €85.46 Million | €82.82 Million | €2.64 Million | €183.41 Million | ▼ -3.1 pp |
| 2015 | 49.7% | €81.87 Million | €81.80 Million | €70.00K | €164.78 Million | ▲ +3.2 pp |
| 2014 | 46.5% | €73.66 Million | €73.59 Million | €71.00K | €158.47 Million | ▼ -6.3 pp |
| 2013 | 52.8% | €76.32 Million | €60.20 Million | €16.12 Million | €144.46 Million | ▲ +10.3 pp |
| 2012 | 42.5% | €53.79 Million | €53.79 Million | €- | €126.45 Million | ▲ +2.3 pp |
| 2011 | 40.2% | €45.86 Million | €45.86 Million | €- | €113.98 Million | ▼ -0.7 pp |
| 2010 | 41.0% | €42.66 Million | €42.66 Million | €- | €104.13 Million | ▼ -4.5 pp |
| 2009 | 45.5% | €32.54 Million | €32.54 Million | €- | €71.50 Million | ▼ -16.0 pp |
| 2008 | 61.6% | €29.82 Million | €29.82 Million | €- | €48.44 Million | ▲ +20.0 pp |
| 2007 | 41.6% | €21.58 Million | €21.58 Million | €- | €51.92 Million | ▼ -12.8 pp |
| 2006 | 54.4% | €14.03 Million | €14.03 Million | €- | €25.81 Million | ▲ +54.4 pp |
| 2005 | 0.0% | €11.33 Million | €11.33 Million | €- | €4.80 Trillion | ▼ -100.9 pp |
| 2004 | 100.9% | €2.94 Million | €2.94 Million | €- | €2.92 Million | ▲ +82.9 pp |
| 2003 | 18.0% | €3.21 Million | €3.21 Million | €- | €17.80 Million | — |